These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

52 related items for PubMed ID: 5670546

  • 1. [Studies on the time relationship of tablet disintegration from some properties and the method of addition of disintegrating agents].
    Krówczyński L, Kolarski K, Swoboda K.
    Acta Pol Pharm; 1968; 25(4):441-6. PubMed ID: 5670546
    [No Abstract] [Full Text] [Related]

  • 2. Cyclodextrin polymer, a new tablet disintegrating agent.
    Fenyvest E, Antal B, Zsadon B, Szejtli J.
    Pharmazie; 1984 Jul; 39(7):473-5. PubMed ID: 6494226
    [Abstract] [Full Text] [Related]

  • 3. In vitro and in vivo evaluation of a fast-disintegrating lyophilized dry emulsion tablet containing griseofulvin.
    Ahmed IS, Aboul-Einien MH.
    Eur J Pharm Sci; 2007 Sep; 32(1):58-68. PubMed ID: 17628451
    [Abstract] [Full Text] [Related]

  • 4. [Calorimetric evaluation of directly compressed tablets].
    Rehula M, Lavická J, Musilová M.
    Ceska Slov Farm; 2001 Jan; 50(1):35-7. PubMed ID: 11242832
    [Abstract] [Full Text] [Related]

  • 5. A comparative study of modified starches in direct compression of a poorly water soluble drug (hydrochlorothiazide).
    Okafor IS, Ofoefule SI, Udeala OK.
    Boll Chim Farm; 2001 Jan; 140(1):36-9. PubMed ID: 11338775
    [Abstract] [Full Text] [Related]

  • 6. Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration.
    Abdelbary G, Eouani C, Prinderre P, Joachim J, Reynier J, Piccerelle P.
    Int J Pharm; 2005 Mar 23; 292(1-2):29-41. PubMed ID: 15725551
    [Abstract] [Full Text] [Related]

  • 7. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD, Dahlöf CG, Brandes JL, Agosti R, Jones MW, Barrett PS.
    Clin Ther; 2005 Apr 23; 27(4):407-17. PubMed ID: 15922814
    [Abstract] [Full Text] [Related]

  • 8. Effects of disintegration-promoting agent, lubricants and moisture treatment on optimized fast disintegrating tablets.
    Late SG, Yu YY, Banga AK.
    Int J Pharm; 2009 Jan 05; 365(1-2):4-11. PubMed ID: 18778759
    [Abstract] [Full Text] [Related]

  • 9. [Studies of the properties of tablets made from directly compressible starch and its mixtures with directly compressible lactose].
    Muzíková J, Moucková E.
    Ceska Slov Farm; 2006 Sep 05; 55(5):236-41. PubMed ID: 17128594
    [Abstract] [Full Text] [Related]

  • 10. Comparison of sublingual tablets with nitroglycerin complexed with beta-cyclodextrin or titrated with crosspovidone--technological approach.
    Centkowska K, Sznitowska M.
    Acta Pol Pharm; 2008 Sep 05; 65(5):585-9. PubMed ID: 19051606
    [Abstract] [Full Text] [Related]

  • 11. Effects of starches on the mechanical properties of paracetamol tablet formulations. II. Sorghum and plantain starches as disintegrants.
    Alebiowu G, Itiola OA.
    Acta Pharm; 2003 Dec 05; 53(4):313-20. PubMed ID: 14769238
    [Abstract] [Full Text] [Related]

  • 12. Influence of compression forces on tablets disintegration by AC Biosusceptometry.
    Corá LA, Fonseca PR, Américo MF, Oliveira RB, Baffa O, Miranda JR.
    Eur J Pharm Biopharm; 2008 May 05; 69(1):372-9. PubMed ID: 18164605
    [Abstract] [Full Text] [Related]

  • 13. The effect of powder blend and tablet structure on drug release mechanisms of hydrophobic starch acetate matrix tablets.
    van Veen B, Pajander J, Zuurman K, Lappalainen R, Poso A, Frijlink HW, Ketolainen J.
    Eur J Pharm Biopharm; 2005 Oct 05; 61(3):149-57. PubMed ID: 16005196
    [Abstract] [Full Text] [Related]

  • 14. Effects of automated external lubrication on tablet properties and the stability of eprazinone hydrochloride.
    Yamamura T, Ohta T, Taira T, Ogawa Y, Sakai Y, Moribe K, Yamamoto K.
    Int J Pharm; 2009 Mar 31; 370(1-2):1-7. PubMed ID: 19059327
    [Abstract] [Full Text] [Related]

  • 15. Rapidly disintegrating risperidone in subjects with schizophrenia or schizoaffective disorder: a summary of ten phase I clinical trials assessing taste, tablet disintegration time, bioequivalence, and tolerability.
    Thyssen A, Remmerie B, D'Hoore P, Kushner S, Mannaert E.
    Clin Ther; 2007 Feb 31; 29(2):290-304. PubMed ID: 17472821
    [Abstract] [Full Text] [Related]

  • 16. Factors affecting the characteristics of rapidly disintegrating tablets in the mouth prepared by the crystalline transition of amorphous sucrose.
    Sugimoto M, Maejima T, Narisawa S, Matsubara K, Yoshino H.
    Int J Pharm; 2005 May 30; 296(1-2):64-72. PubMed ID: 15885456
    [Abstract] [Full Text] [Related]

  • 17. Influence of binder properties, method of addition, powder type and operating conditions on fluid-bed melt granulation and resulting tablet properties.
    Abberger T.
    Pharmazie; 2001 Dec 30; 56(12):949-52. PubMed ID: 11802658
    [Abstract] [Full Text] [Related]

  • 18. Material and tablet properties of pregelatinized (thermally modified) Dioscorea starches.
    Odeku OA, Schmid W, Picker-Freyer KM.
    Eur J Pharm Biopharm; 2008 Sep 30; 70(1):357-71. PubMed ID: 18562187
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of rapidly disintegrating tablets manufactured by phase transition of sugar alcohols.
    Kuno Y, Kojima M, Ando S, Nakagami H.
    J Control Release; 2005 Jun 20; 105(1-2):16-22. PubMed ID: 15955365
    [Abstract] [Full Text] [Related]

  • 20. [Influence of binding and disintegrating agents on the texture of tablets with calcium monohydrogen phosphate base].
    François A, Gillard J, Roland M.
    J Pharm Belg; 1972 Jun 20; 27(2):187-220. PubMed ID: 5037059
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.